My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 407

    1.

    GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes.

    Mayr A, Schlosser M, Grober N, Kenk H, Ziegler AG, Bonifacio E, Achenbach P.

    Diabetes. 2007 Jun;56(6):1527-33. Epub 2007 Feb 26.PMID: 17325256 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.

    Kimpimäki T, Kulmala P, Savola K, Kupila A, Korhonen S, Simell T, Ilonen J, Simell O, Knip M.

    J Clin Endocrinol Metab. 2002 Oct;87(10):4572-9.PMID: 12364437 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk.

    Schlosser M, Koczwara K, Kenk H, Strebelow M, Rjasanowski I, Wassmuth R, Achenbach P, Ziegler AG, Bonifacio E.

    Diabetologia. 2005 Sep;48(9):1830-2. Epub 2005 Jul 12.PMID: 16010521 [PubMed - indexed for MEDLINE]Related articles

    4.

    Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes.

    Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E.

    J Clin Invest. 2004 Aug;114(4):589-97.PMID: 15314696 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.

    Desai M, Cull CA, Horton VA, Christie MR, Bonifacio E, Lampasona V, Bingley PJ, Levy JC, Mackay IR, Zimmet P, Holman RR, Clark A.

    Diabetologia. 2007 Oct;50(10):2052-60. Epub 2007 Jul 27.PMID: 17657474 [PubMed - indexed for MEDLINE]Related articles

    6.

    IA-2 autoantibodies predict impending type I diabetes in siblings of patients.

    Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Weets I, Vandemeulebroucke E, Truyen I, Kaufman L, Schuit FC, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

    Diabetologia. 2002 Dec;45(12):1658-66. Epub 2002 Nov 12.PMID: 12488955 [PubMed - indexed for MEDLINE]Related articles

    7.

    Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings.

    Korhonen S, Knip MM, Kulmala P, Savola K, Akerblom HK, Knip M; Finnish Study Group for ICA Screening.

    Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):43-8.PMID: 11921417 [PubMed - indexed for MEDLINE]Related articles

    8.

    Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.

    Westerlund A, Ankelo M, Ilonen J, Knip M, Simell O, Hinkkanen AE.

    J Autoimmun. 2005 Mar;24(2):153-67.PMID: 15829408 [PubMed - indexed for MEDLINE]Related articles

    9.

    Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.

    Ferber KM, Keller E, Albert ED, Ziegler AG.

    J Clin Endocrinol Metab. 1999 Jul;84(7):2342-8.PMID: 10404800 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.

    Schlosser M, Banga JP, Madec AM, Binder KA, Strebelow M, Rjasanowski I, Wassmuth R, Gilliam LK, Luo D, Hampe CS.

    Diabetologia. 2005 May;48(5):922-30. Epub 2005 Apr 16.PMID: 15834701 [PubMed - indexed for MEDLINE]Related articles

    11.

    Time-resolved immunofluorometric dual-label assay for simultaneous detection of autoantibodies to GAD65 and IA-2 in children with type 1 diabetes.

    Ankelo M, Westerlund A, Blomberg K, Knip M, Ilonen J, Hinkkanen AE.

    Clin Chem. 2007 Mar;53(3):472-9. Epub 2007 Jan 26.PMID: 17259239 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.

    Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Kockum I, Rolandsson O, Landin-Olsson M, Törn C, Persson B, Lernmark A.

    J Clin Endocrinol Metab. 2000 Dec;85(12):4671-9.PMID: 11134126 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes.

    Bonifacio E, Lampasona V, Bernasconi L, Ziegler AG.

    Diabetes. 2000 Feb;49(2):202-8.PMID: 10868936 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives.

    Pastore MR, Bazzigaluppi E, Bonfanti R, Dozio N, Sergi A, Balini A, Belloni C, Meschi F, Bonifacio E, Bosi E.

    Diabetes Care. 1998 Sep;21(9):1445-50.PMID: 9727889 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.

    Buzzetti R, Di Pietro S, Giaccari A, Petrone A, Locatelli M, Suraci C, Capizzi M, Arpi ML, Bazzigaluppi E, Dotta F, Bosi E; Non Insulin Requiring Autoimmune Diabetes Study Group.

    Diabetes Care. 2007 Apr;30(4):932-8.PMID: 17392553 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Genetic risk determines the emergence of diabetes-associated autoantibodies in young children.

    Kupila A, Keskinen P, Simell T, Erkkilä S, Arvilommi P, Korhonen S, Kimpimäki T, Sjöroos M, Ronkainen M, Ilonen J, Knip M, Simell O.

    Diabetes. 2002 Mar;51(3):646-51.PMID: 11872662 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.

    Ziegler B, Schlosser M, Lühder F, Strebelow M, Augstein P, Northemann W, Powers AC, Ziegler M.

    Acta Diabetol. 1996 Sep;33(3):225-31.PMID: 8904930 [PubMed - indexed for MEDLINE]Related articles

    18.

    The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.

    Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P, Falorni A, Buzzetti R; NIRAD Study Group.

    Diabetes Care. 2008 Mar;31(3):534-8. Epub 2007 Dec 4.PMID: 18056891 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Epitope analysis of GAD65 autoantibodies in Japanese patients with autoimmune diabetes.

    Kawasaki E, Abiru N, Ide A, Sun F, Fukushima T, Takahashi R, Kuwahara H, Fujita N, Kita A, Oshima K, Uotani S, Yamasaki H, Yamaguchi Y, Eguchi K.

    Ann N Y Acad Sci. 2003 Nov;1005:440-8.PMID: 14679108 [PubMed - indexed for MEDLINE]Related articles

    20.

    Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes.

    Ronkainen MS, Hoppu S, Korhonen S, Simell S, Veijola R, Ilonen J, Simell O, Knip M.

    Eur J Endocrinol. 2006 Oct;155(4):633-42.PMID: 16990664 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity